SLC5A2 and Insulin resistance: SGLT2 inhibition opposes some of the adverse effects of DM and insulin resistance on cardiovascular metabolism and function, improving oxygen delivery, cardiac fuel energetics, and mitochondrial function [37], [38], [39], [40].